In this commentary, James Matera, DO, writes about the ESRD treatment choice model that started on January 1, 2021, as well as its importance to and implications for practitioners.
In this Top Papers column, James Matera, DO, writes about 3 important research papers that highlight new potential treatment options for patients with CKD and anemia, and those with CKD and cardiovascular...
In this video, James Matera, DO, gives a preview of his presentation on the differences between NASH and NAFLD, which will be presented at the Practical Updates in Primary Care 2020 Virtual Series on...
James Matera, DO, discusses optimal blood pressure targets in patients with kidney disease, and how the 2017 AHA/ACC hypertension guidelines affect these targets.
Dr Awan discusses the management of hepatitis C virus infection among patients with chronic kidney disease according to the most recent clinical practice guideline from Kidney Disease: Improving Global...
James Matera, DO, discusses the US Department of Health and Human Services' 'Advancing American Kidney Health' initiative and what it means for nephrologists and primary care physicians.
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
Emerging data suggest that acute kidney injury may have long-term cerebrovascular consequences, including heightened dementia risk. Consultant360 spoke with Dr Jessica Kendrick from the University of...
Andrew Meltzer, MD, from the George Washington University School of Medicine and Health Sciences, discusses his latest research, which suggests that tamsulosin may not be effective for certain ureteral...
Diabetes, cardiovascular disease, and kidney disease are leading causes of death in the United States, but what else do they have in common? In this Q&A, Dr Thomas Zelniker explains how these 3 diseases...
